PubRank

Ali J Marian

Author PubWeight™ 37.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006 3.22
2 Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009 2.50
3 A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 2005 2.42
4 Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res 2012 2.25
5 Surprises of the genome and "personalized" medicine. J Am Coll Cardiol 2008 1.84
6 Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci U S A 2003 1.74
7 Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res 2007 1.51
8 Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study. Eur J Clin Invest 2010 1.47
9 Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. Cardiovasc Res 2008 1.33
10 Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation 2009 1.30
11 Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 2009 1.28
12 Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet 2007 1.23
13 The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. BMC Cardiovasc Disord 2009 1.18
14 Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 2007 1.16
15 Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc Natl Acad Sci U S A 2005 1.09
16 Nature's genetic gradients and the clinical phenotype. Circ Cardiovasc Genet 2009 1.04
17 Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Invest 2010 0.97
18 Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy. Circ Cardiovasc Genet 2011 0.93
19 Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells. Curr Opin Cardiol 2010 0.90
20 Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity. Cardiovasc Res 2012 0.90
21 Phenotypic plasticity of sarcomeric protein mutations. J Am Coll Cardiol 2007 0.89
22 Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury. Am J Physiol Heart Circ Physiol 2013 0.86
23 Can an energy-deficient heart grow bigger and stronger? J Am Coll Cardiol 2003 0.80
24 Noncoding RNAs in cardiovascular biology and disease. Circ Res 2013 0.77
25 FAT10 protects cardiac myocytes against apoptosis. J Mol Cell Cardiol 2013 0.77
26 Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest 2011 0.76
27 DNA sequence variants and the practice of medicine. Curr Opin Cardiol 2010 0.76
28 Clinical significance of single nucleotide polymorphisms in PCSK9. Curr Atheroscler Rep 2007 0.75
29 A novel genetic risk factor for myocardial infarction. Curr Atheroscler Rep 2007 0.75
30 Genome-wide association study of susceptibility alleles for coronary artery disease. Curr Atheroscler Rep 2008 0.75
31 Interleukin-18 and cardiovascular events. Curr Atheroscler Rep 2006 0.75
32 Pharmacogenetic study of statin therapy and cholesterol reduction. Curr Atheroscler Rep 2005 0.75
33 Matrix metalloproteinase-I gene variants and risk of myocardial infarction. Curr Atheroscler Rep 2006 0.75
34 Errors in DNA replication and genetic diseases. Curr Opin Cardiol 2013 0.75
35 Ali J. Marian: life and science are one. Circ Res 2014 0.75
36 Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study. Curr Atheroscler Rep 2005 0.75